Roberto Pilloton

Dr. Roberto Pilloton

CNR - Istituto di Cristallografia
+1
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Chemical Engineering Journal
Verified
Journal Article
Closed access
SSShariq Suleman
Shariq Suleman
SSSudheesh K. Shukla
Sudheesh K. Shukla
NMNitesh Malhotra
Nitesh Malhotra
SBShikandar D. Bukkitgar
Shikandar D. Bukkitgar
NSNagaraj P. Shetti
Nagaraj P. Shetti
TATejraj M. Aminabhavi
Tejraj M. Aminabhavi

1 August 1995 in Analytica Chimica Acta
Verified
Journal Article
Closed access
CCC. Cremisini
C. Cremisini
SSS. Di Sario
S. Di Sario
JMJ. Mela
J. Mela
Roberto PillotonRoberto Pilloton
Roberto Pilloton
GPG. Palleschi
G. Palleschi

6 February 2002 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
MKMichal Koblizek
Michal Koblizek
JMJan Malý
Jan Malý
JMJiří Masojídek
Jiří Masojídek
JKJosef Komenda
Josef Komenda
TKTomáš Kučera
Tomáš Kučera
Roberto PillotonRoberto Pilloton
Roberto Pilloton

1 July 2010 in Journal of Molecular Catalysis B: Enzymatic
Verified
Journal Article
Closed access
MMM.R. Montereali
M.R. Montereali
LSL. Della Seta
L. Della Seta
WVW. Vastarella
W. Vastarella
Roberto PillotonRoberto Pilloton
Roberto Pilloton

1 June 2022 in Sensors
Verified
Journal Article
Open access
PDF file
SMShouvik Mukherjee
Shouvik Mukherjee
SSShariq Suleman
Shariq Suleman
Roberto PillotonRoberto Pilloton
Roberto Pilloton
JNJagriti Narang
Jagriti Narang
Kirti RaniKirti Rani
Kirti Rani
Several illnesses that are chronic and acute are becoming more relevant as the world’s aging population expands, and the medical sector is transforming rapidly, as a consequence of which the need for “point-of-care” (POC), identification/detection, and real time management of health issues that have been required for a long time are increasing. Biomarkers are biological markers that help to detect status of health or disease. Biosensors’ applications are for screening for early detection, chronic disease treatment, health management, and well-being surveillance. Smart devices that allow continual monitoring of vital biomarkers for physiological health monitoring, medical diagnosis, and assessment are becoming increasingly widespread in a variety of applications, ranging from biomedical to healthcare systems of surveillance and monitoring. The term “smart” is used due to the ability of these devices to extract data with intelligence and in real time. Wearable, implantable, ingestible, and portable devices can all be considered smart devices; this is due to their ability of smart interpretation of data, through their smart sensors or biosensors and indicators. Wearable and portable devices have progressed more and more in the shape of various accessories, integrated clothes, and body attachments and inserts. Moreover, implantable and ingestible devices allow for the medical diagnosis and treatment of patients using tiny sensors and biomedical gadgets or devices have become available, thus increasing the quality and efficacy of medical treatments by a significant margin. This article summarizes the state of the art in portable, wearable, ingestible, and implantable devices for health status monitoring and disease management and their possible applications. It also identifies some new technologies that have the potential to contribute to the development of personalized care. Further, these devices are non-invasive in nature, providing information with accuracy and in given time, thus making these devices important for the future use of humanity.

1 January 2004 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
STSuna Timur
Suna Timur
NPNurdan Pazarlıoǧlu
Nurdan Pazarlıoǧlu
Roberto PillotonRoberto Pilloton
Roberto Pilloton
ATAzmi Telefoncu
Azmi Telefoncu